Micronutrient Deficiencies and Their Impact on Hospitalization Duration in Pediatric Palliative Care: A Retrospective

Doğukan Mustafa Keskin1, Ayhan Çeri1

  • 1Department of Pediatrics, Dr. Ali Kemal Belviranlı Obstetrics and Gynecology Hospital, Konya, Türkiye.

PubMed

Insights

Micronutrient deficiencies, particularly low vitamin D, are common in pediatric palliative care patients and linked to longer hospital stays. Enteral nutrition support also predicts prolonged hospitalization.

Area of Science:

  • Pediatric Palliative Care
  • Clinical Nutrition
  • Micronutrient Metabolism

Background:

  • Pediatric palliative care (PPC) patients often face complex health challenges.
  • Micronutrient deficiencies can impact patient outcomes and hospital stay duration.
  • Understanding these deficiencies is crucial for optimizing care in PPC.

Purpose of the Study:

  • To determine the prevalence of micronutrient deficiencies in hospitalized PPC patients.
  • To investigate the association between these deficiencies and the length of hospital stay.

Main Methods:

  • Retrospective analysis of 81 children in a PPC unit.
  • Assessed serum levels of ferritin, vitamin D, vitamin B12, and folate.
  • Compared clinical and laboratory data based on short (≤5 days) vs. long (>5 days) hospital stays using logistic regression.

Main Results:

  • 45.68% of patients had at least one micronutrient deficiency.
  • Prolonged hospital stays correlated with higher ferritin and lower vitamin D levels.
  • Enteral nutrition support (OR: 4.931) and lower vitamin D levels (OR: 0.937) predicted longer hospitalizations.

Conclusions:

  • Lower vitamin D levels and the need for enteral nutrition support are significant predictors of prolonged hospitalization in PPC.
  • Routine micronutrient screening and targeted interventions may improve patient outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
232
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
702
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
620